BFM
LEXXW

Boothbay Fund Management’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Boothbay Fund Management’s Portfolio LEXXW Stock Details LEXXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-78,950
Closed -$98.7K – 1770
2023
Q4 		$98.7K Hold
78,950
– – ﹤0.01% 1432
2023
Q3 		$78.9K Hold
78,950
– – ﹤0.01% 1591
2023
Q2 		$57.7K Hold
78,950
– – ﹤0.01% 1668
2023
Q1 		$215K Hold
78,950
– – ﹤0.01% 1699
2022
Q4 		$194K Hold
78,950
– – ﹤0.01% 1627
2022
Q3 		$193K Hold
78,950
– – ﹤0.01% 1861
2022
Q2 		$235K Hold
78,950
– – 0.01% 1625
2022
Q1 		$261K Hold
78,950
– – 0.01% 1707
2021
Q4 		$318K Hold
78,950
– – 0.01% 1231
2021
Q3 		$494K Hold
78,950
– – 0.01% 1092
2021
Q2 		$553K Hold
78,950
– – 0.02% 951
2021
Q1 		$443K Buy
+78,950
New +$173K 0.02% 1005

Other funds holding LEXXW

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boothbay Fund Management's LEXXW Position: Q1 2024 in Review

Boothbay Fund Management sold out of Lexaria Bioscience Warrant (LEXXW) in Q1 2024, closing a stake of 78,950 shares — an estimated $98.7K sold.

Boothbay Fund Management first reported a position in LEXXW in Q1 2021 and held it in 12 quarters. The position peaked at $553K in Q2 2021. 3 funds tracked by Wall St. Rank hold LEXXW as of Q1 2024.

  • Boothbay Fund Management reported no remaining Lexaria Bioscience Warrant position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 78,950 Lexaria Bioscience Warrant shares in Q1 2024, an estimated $98.7K.
  • Boothbay Fund Management first reported a position in Lexaria Bioscience Warrant in Q1 2021 and held it in 12 quarters.
  • Boothbay Fund Management's Lexaria Bioscience Warrant position peaked at $553K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.